What is ISSCR?

ISSCR Leadership

Committees

Annual Meeting

ISSCR Membership

ISSCR Newsletter

Glossary

Related Journal Articles

Links

Bylaws

Contact ISSCR Headquarters

ISSCR Newsletter
Volume 1, No. 3
November 2002

Editor's Note
Suzanne Kadereit, Ph.D.
Case Western Reserve University
Cleveland, OH

The ISSCR Newsletter is published quarterly for members and friends of the International Society for Stem Cell Research.

Your feedback and submissions to this newsletter are encouraged. Send information, updates, calendar listings, citations and other material for consideration to the editor at sxk79@po.cwru.edu or to ISSCR Headquarters at psullivan@isscr.org.

Lastly, I encourage you to forward this newsletter to individuals who might be interested in joining our new stem cell research society.

In This Issue:

President's Message

Dear Members:

The ISSCR continues to grow in its membership and one of its missions is to provide interconnectivity to researchers, the lay public, government and reporters.

Perhaps the best mechanism for our Society to establish this communication is through our website. We are in the process of securing funding to allow us to alter our website so that it is a better interactive source of information. Below I have listed our goals with respect to the website.

I am looking for feedback and also interesting ideas that we can list on the website.

We plan to utilize state of the art graphics with language that can be understood by the lay audience as well as experienced investigators.

The improvement in the website will be predominantly based on two aspects: 1) improvement in design; and 2) the hiring of dedicated individuals who are focused on the website.

In particular, one individual will work on the daily upkeep and the creation of new links. The other person will focus on scientific aspects regarding stem cell biology, community and interactions among investigators in the field, members of the ISSCR, as well as interactions with other foundations.

The following items will be included on the website:

1) Definitions. Even in its perfunctory form, we have found that many reporters and government officials are utilizing the website for definitions of terminology. We plan to update these definitions. Such definitions will remain simple and straightforward, and in the future could be illustrated. For instance, the process of nuclear cloning will be described for senior investigators and for the lay public.

2) Ethical Discussions. The Board is lucky to have Laurie Zoloth as a member. She has been extremely influential in the bioethics of stem cells and has authored several publications and books on this matter. We plan to develop ethical statements that will be posted on our website. This can then be utilized by government officials, as well as reporters, for a better understanding and promotion of discussion among the various groups developing opinions on stem cell derivation and use. We also plan to develop position statements for the ISSCR. For instance, Rudy Janesch has developed a statement on cloning that is currently being reviewed by our Policy Committee. This will be posted on our website.

3) Literature search. It is very important that the stem cell field maintain up-to-date resources. For instance, I was recently asked by the Australian government for a complete compilation of stem cell literature regarding the use of human embryonic stem cells. It was possible to obtain the National Academy of Sciences reports and a link from our website, but it would also be important to proactively generate literature searches that could be used for a variety of purposes.

4) Bringing membership together. Our website will link stem cell researchers. Since our membership encompasses much of the community and in particular, our Board and committee members form many of the leaders, we think we are in a unique position to bring stem cell researchers together through our website. Our website will list contact information for members and searchable areas of expertise (using key words). Over the next couple of years, we will develop user groups among stem cell researchers, lay people and government officials. This will allow links so that information about stem cell biology can be available to the community and potential collaborations can be fostered.

5) Job searching. It is clear that a number of academic institutes and industry are now generating stem cell biology jobs, including professorships and junior faculty. It is critical to hire high quality investigators and this can be advertised through our website.

6) Grant opportunities for stem cell researchers. It is clear that there are many mechanisms to fund stem cell researchers. Many institutions, associations, and foundations want a better view of the investigators and topics relevant to their interests. This aspect of the website will be invaluable for furthering the field as we attempt to bring stem cells to the bedside. This may be an excellent resource for initiating collaborations.

7) Creating new alliances. Several academic websites have links to stem cell biology. Interconnectivity is very important and the website. The connector of these sites will be facilitated with a dedicated person working on the science of the field.

8) Meetings. There are numerous stem cell meetings and a focused website delineating these times and places will be extremely useful for the community.

9) Storage of Newsletters. We plan to create a library of our Newsletters, so that new members can have up-to-date information.

10) Listing of available Human ES and EG lines. As many of you know, there are currently only a few lines available. The website can list these with information such as karyotype analysis, etc.

As you can see, this is an all encompassing plan. Our hope is that the hiring of a full time science editor will facilitate many of these goals and will establish more connections within the stem cell field.

Sincerely,

Leonard I. Zon, M.D.
ISSCR President

Back to Top


News

Human stem cell bank:
Financed by a grant from the MRC (U.K.), the first bank for worldwide collection and distribution of stem cell lines derived from human embryos, fetal and adult tissues should be opening within a year.

Availability of NIH-approved human ES cell lines:

Although a long list of human embryonic stem cell lines has been approved by the NIH for use in federally funded US labs, actual availability seems to have been scarce up to now. The NIH awarded several infrastructure grants to facilitate growing and distribution of the approved cell lines. Hopefully the supply bottleneck will soon be passed.

If you have cell lines included in the NIH list in your laboratory and need additional support for distribution to the research community, please contact:
Dr. John W. Thomas
Division of Blood Diseases and Resources / NHLBI / NIH
Phone: 301-435-0050
E-mail: ThomasJ@nhlbi.nih.gov


Human stem cell legislation:

Australia:
Legislation supposed to be passed in August, banning human cloning, but allowing use and derivation of human ES cells, has been postponed to December 2003.

Canada:
Somatic nuclear transfer prohibited, but derivation of new ES cell lines allowed.

European Union:
The debate still goes on whether to allow derivation of new ES cell lines under the 6th Framework Program. There will probably be a moratorium on derivation of new cell lines until December 2003 for funding under this Framework Program.

Austria, Italy, Ireland and Spain:
Work on human ES cell lines and embryos is banned, Spain is considering new legislation.

Belgium:
Research on embryos is allowed, reproductive cloning is prohibited.

Germany:
Import of cell lines existing before January 2002 is allowed if approved by a national review board.

France:
New legislation is on hold, due to government change. Interim regulation allowing import of existing cell lines also on hold.

Netherlands:
Research is allowed on human embryos when there is no reasonable alternative, reproductive cloning is banned.

Sweden:
Derivation of new embryonic stem cell lines allowed, reproductive cloning prohibited.

United Kingdom:
Stem cell lines can be derived from human embryos, nuclear transfer to create cell lines also allowed.

India:
No specific laws governing embryo research, derivation and use of human ES cells are subject of approval by institution's internal review boards. New legislation pending that would prohibit export of any part of an embryo.

Israel:
Research on embryos allowed, similar to Sweden.

Japan:
With approval of local and national ethics review board, derivation and use of human ES cell lines permitted, human cloning banned.

Korea:
Legislation pending allowing work on surplus embryos, but banning of human reproductive cloning. Decisions on allowing the use of somatic nuclear transfer to create stem cells will be left to a bioethics committee.

Singapore:
Currently, ES cell research and therapeutic cloning permitted. Pending legislation banning human reproductive cloning.

United States:
For federally funded researchers only use of cell lines posted on the NIH web site is permitted. California passed state law (September 22) explicitly allowing researchers to derive ES cell lines and to clone embryos to study and treat diseases (regulated by institutional review boards), thus opening private and state funding. Temporary ban on reproductive cloning has been made permanent.

Back to Top


Forum

Announcement by Una Chen, PhD, Head of the Stem Cell Therapy Program at the University of Giessen (Germany):

Dear Colleagues,

We are planning a publication on the origins of stem cell research
and on the people that were involved in it.

Much attention has been drawn recently to stem cells. It has become
a frequent topic of public debate and dinner table conversation. Most
people, however, know nothing about the pioneers who have spent many silent years of hard work creating this field during its dark stone age. I have
been discussing this question with several of the leaders in the field and
would like to invite you to contribute to this article so that your
experiences can be shared by readers who are interested in learning more
about stem cell research and its researchers.

You are more than welcome to spread the word to people who may not
have received this message so that their voices can be heard and documented and their discoveries discussed.

We aim to focus our attention to totipotent stem cells and tissue-specific stem cells of all species but are quite open to suggestions.

Looking forward to hearing from you,

Una Chen, Ph.D.-U.C.Berkeley
Head of Stem Cell Therapy Program
Med. Microbiology Institute
University of Giessen, Friedrichstrasse 24 D-35392 Giessen, Germany
Tel & FAX: +49-641-99-47459 (Office)
E-mail addresses: Una.Chen@gmx.de or
Una.Chen@mikrobio.med.uni-giessen.de
http://www.med.uni-giessen.de/biochem/

Back to Top


Funding

UNITED KINGDOM:

Alzheimer's Research Trust:
Dementia Research
Deadline: November 8, 2002
http://www.alzheimers-research.org.uk/scientists
http://www.qrd.ion.ucl.ac.uk

Research into Aging:
Call for proposals for research carried out in U.K., exception: cancer research
Deadline: several, depending on program
http://www.ageing.org
Address: Research into Ageing, PO Box 32833, London N1 9ZQ
Tel: 020- 7843-1572

GERMANY:

Humboldt Research Fellowship Program:
All research plans, conducted in German institutions.
Deadline: Applications are accepted at any time
http://www.humboldt-foundation.de
avh@bellatlantic.net

UNITED STATES:

NIGMS
NIGMS has announced two initiatives to encourage and facilitate basic research involving human embryonic stem cells. The first announcement is for administrative supplements to NIGMS grantees. The receipt date for requests for administrative supplements is May 5, 2003. The second announcement is an RFA for Exploratory Center Grants for Human Embryonic Stem Cell Research.

The receipt date for this RFA is March 13, 2003. Details of these initiatives can be found at http://www.nigms.nih.gov/funding/stemcells.html. In addition, this site contains links to the report of the NIGMS Workshop on the Basic Biology of Mammalian Stem Cells and to other resources for human embryonic stem cell research.

Questions about the Notice for Administrative Supplements can be addressed to a grantee's NIGMS program director. Questions about the RFA for Exploratory Center Grants may be addressed to:
Marion M. Zatz, Ph.D.
Zatzm@NIGMS.NIH.Gov
301-594-0943 Phone
301-480-2228 FAX

State of New Jersey Commission on Spinal Cord Research
Basic or clinical research on spinal cord injury and disease ($200,000/year, 1-2 years).
Deadline: January 3, 2003
http://www.state.nj.us/health/spinalcord/
Tel: 609-292-4055
njscr@doh.state.nj.us

McKnight Endowment Fund for Neuroscience:
Scholar Awards:
Deadline: January 2, 2003
Technological Innovation Awards:
Deadline (Letter of Intent): December 1, 2002
Brain Disorders Awards:
Deadline (Letter of Intent): May, 2003.
http://www.mcknight.org/neuroscience

Back to Top


Stem Cell Meetings Calendar

2002

October 15-19
American Society of Human Genetics
Baltimore, MD
www.faseb.org/genetics/ashg/ashgmenu

November 18-20
12th Takeda Science Foundation Symposium on Bioscience
"Stem Cells and Organogenesis"
Registration deadline: October 11, 2002
International Conference Center Kobe, Hyogo, Japan
takedasci@congre.co.jp
http://www.congre.co.jp/takedasci/

December 6-10
44th American Society of Hematology (ASH) Annual Meeting
Convention Center
Philadelphia, Pennsylvania
http://www.hematology.org/meeting/

2003

June 8-11
International Society for Stem Cell Research
First Annual Scientific Meeting & Exhibition
Washington, DC
For more information, see the ISSCR meetings page

January 30-February 3
American Society for Blood and Marrow Transplantation
Keystone, CO
www.asbmt

February 13-18
American Association for the Advancement of Science
Denver, Colorado
www.aaas.org

March 13-14
VIth International Meeting on In Utero Stem Cell Transplantation and Gene Therapy
Lyon, France
http://www.fondation-merieux.org

June 4-8
American Society of Gene Therapy
Washington, DC
www.asgt.org

June 13-18
52nd Annual Montagna Symposium on the Biology of the Skin
"Stem Cells of Epithelia"
Snowmass, CO
http://www.montagnasymposium.org/

July 5-9
International Society for Experimental Hematology
Palais des Congres Paris, France
www.iseh.org

July 30-August 2
Society for Developmental Biology
Boston, MA
www.sdb.bio.purdue.edu

Keystone Symposia of potential interest:
http://www.keystonesymposia.org

January 21-26
Toward Understanding Islet Biology (J1)
Keystone, CO

February 11-16
Optical Imaging: Applications to Biology and Medicine (C2)
Taos, NM
Session on optical imaging in stem cells on Thursday 13th.

March 29-April 3
From Stem Cells to Therapy (E3)
Steamboat Springs, CO

Send meetings to be listed in the calendar to ISSCR headquarters:
isscr@isscr.org

Back to Top


Industrial Meetings


2003

January 15-16
Stem Cells & Cloning: Development and Opportunities
Asia/Pacific conference to promote cooperation, increase investments and awareness in the stem cells industry.
Singapore
www.ibc-asia.com/stemcells.htm

Back to Top


Resources

Reports and Discussion Papers by the Nuffield Council on Bioethics, London, U.K.:

http://www.nuffieldbioethics.org
"The Nuffield Council on Bioethics is an independent body established by the Trustees of the Nuffield Foundation in 1991 to consider the ethical issues arising from developments in medicine and biology. The Council is funded jointly by the Nuffield Foundation, The Wellcome Trust and the Medical Research Council."

Reports and Discussion papers among others, on:
Stem Cell Therapy: ethical issues 2000
Animal-to-human transplants: the ethics of xenotransplantation 1996
Human tissue: ethical and legal issues 1995

Copies in CD-ROM form of reports and discussion papers can also be requested at bioethics@nuffieldfoundation.org, or downloaded from their website.

Back to Top


Reviews

July Issue of Journal of Pathology, vol 197, with reviews on prostatic, neural, lung epithelial, pancreatic, hepatic, gastrointestinal, epidermal, cardiac, muscle, hematopoietic, and embryonic stem cells.

Burdon T, Smith A, Savatier P (2002)."Signalling, cell cycle and pluripotency in embryonic stem cells."Trends Cell Biol 12:432.

Bradley JA, Bolton EM, Pedersen RA (2002). "Stem cell medicine encounters the immune system." Nat Rev Immunol. 2:859.

Daley G (2002)."Prospects for stem cell therapeutics: myths and medicines." Curr Opin Genet Dev 12:607.

Eiges R, Benvenisty N (2002)."A molecular view on pluripotent stem cells." FEBS Lett 529:135.

Frisen J (2002)."Stem cell plasticity?" Neuron 35:415.

Noel D, Djouad F, Jorgense C (2002). "Regenerative medicine through mesenchymal stem cells for bone and cartilage repair." Curr Opin Investig Drugs 3:1000.

Presnell S, Petersen B, Heidaran M (2002)."Stem cells in adult tissues." Semin Cell Dev Biol 13:369.

Tisdale JF, Dunbar CE (2002)."Plasticity and hematopoiesis: Circe's transforming potion?" Curr Opin Hematol 9:268.

Weissman IL (2002). "The road ended up at stem cells." Immunol Rev. 185:159.

Wilmut I, Beaujean N, De Sousa PA, Dinnyes A, King TJ, Paterson LA, Wells DN, Young LE (2002)."Somatic cell nuclear transfer." Nature 419:583.

Back to Top


Methods Papers

Asano T, Hanazono Y, Ueda Y, Muramatsu S, Kume A, Suemori H, Suzuki Y, Kondo Y, Harii K, Hasegawa M, Nakatsuji N, Ozawa K (2002)."Highly efficient gene transfer into primate embryonic stem cells with a simian lentivirus vector." Mol Ther 6:162.

Falk A, Holmstrom N, Carlen M, Cassidy R, Lundberg C, Frisen J (2002)."Gene delivery to adult neural stem cells." Exp Cell Res 279:34.

Fijnvandraat AC, De Boer PA, Deprez RH, Moorman AF (2002)."Non-radioactive in situ detection of mRNA in ES cell-derived cardiomyocytes and in the developing heart." Microsc Res Tech 58:387.

Levsky JM, Shenoy SM, Pezo RC, Singer RH. (2002). "Single-cell gene expression profiling." Science, 297:836.

Murphy CL, Polak JM (2002)."Differentiating Embryonic Stem Cells: GAPDH, But Neither HPRT Nor beta-Tubulin Is Suitable as an Internal Standard for Measuring RNA Levels." Tissue Eng 8:551.

Nagano M, Watson DJ, Ryu BY, Wolfe JH, Brinster RL (2002)." Lentiviral vector transduction of male germ line stem cells in mice." FEBS Lett 524:111.

Pedersen RA (2002)."Feeding hungry stem cells." Nat Biotechnol 20:882-3.
Rathjen J, Rathjen P (2002)."Recipes for cooking with stem cells." Trends Cell Biol 12:447.

Back to Top


Articles

Castro, RF, Jackson KA, Goodell MA, Robertson CS, Liu H, Shine HD (2002)." Failure of bone marrow cells to transdifferentiate into neural cells in vivo." Science 297:1299.

Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J, Reubinoff B, Mandelboim O, Benvenisty N (2002)."Characterization of the expression of MHC proteins in human embryonic stem cells." Proc Natl Acad Sci U S A 99:9864.

Hackney JA, Charbord P, Brunk BP, Stoeckert CJ, Lemischka IR, Moore KA (2002)."A molecular profile of a hematopoietic stem cell niche." Proc Natl Acad Sci U S A 99:13061.

Hanna LA, Foreman RK, Tarasenko IA, Kessler DS, Labosky PA (2002)."Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo." Genes Dev 20:2650.

Heyworth C, Pearson S, May G, Enver T (2002)."Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells." EMBO J. 21:3770.

Humpherys D, Eggan K, Akutsu H, Friedman A, Hochedlinger K, Yanagimachi R, Lander ES, Golub TR, Jaenisch R (2002)."Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei." Proc Natl Acad Sci U S A 99:12889.

Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR (2002).
A stem cell molecular signature. Science, 298:601.

Jirmanova L, Afanassieff M, Gobert-Gosse S, Markossian S, Savatier P (2002)." Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells."
Oncogene 21:5515.

Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sanchez-Pernaute R, Bankiewicz K, McKay R. (2002) "Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease." Nature, 418:50.

Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA (2002). "Stemness": transcriptional profiling of embryonic and adult stem cells." Science 298:597.

Schmidt M, Zickler P, Hoffmann G, Haas S, Wissler M, Muessig A, Tisdale JF, Kuramoto K, Andrews RG, Wu T, Kiem HP, Dunbar CE, von Kalle C (2002)."Polyclonal long-term repopulating stem cell clones in a primate model." Blood. 100:2737.

Tsai EJ, Malech HL, Kirby MR, Hsu AP, Seidel NE, Porada CD, Zanjani ED, Bodine DM, Puck JM (2002)."Retroviral transduction of IL2RG into CD34(+) cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras." Blood100:72.

Wagers AJ, Sherwood RI, Christensen JL, Weissman IL (2002)."Little evidence for developmental plasticity of adult hematopoietic stem cells." Science 297:2256.

Xu C, Police S, Rao N, Carpenter MK (2002). Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells."Circ Res 91:501.

Back to Top

© 2002 All rights reserved. International Society for Stem Cell Research


Return to Newsletters Page

 

© 2002 All rights reserved.
International Society for Stem Cell Research 
60 Revere Drive, Suite 500  Northbrook, IL 60062 USA
phone 847-509-1944 · fax 847-480-9282 · isscr@isscr.org